May 19, 2025

From rockets to roadmaps: Redefining success in pharma launches

It’s time to rethink what a successful pharma launch looks like.

Are you stuck in a cycle of rigid timelines and siloed teams? Are you building your launch on outdated assumptions? It’s time to transform launches. You can start by reading the full workshop summary from Pharmageddon USA. 

In April 2025, senior leaders from AstraZeneca, GSK, Lilly, Biogen, Sanofi, Novartis, Chiesi, and more gathered in Philadelphia with one question: Why, despite more data and larger budgets, are launches still missing the mark?

Hosted by Impatient Health and Within3, the session challenged participants to confront hard truths about launch failures—and to explore how AI, adaptability, and insight-driven decision-making could change the game.

Launches aren’t failing for lack of data—they’re failing because strategy can’t keep up

The session invited attendees to think of a launch as a car journey, not a rocket launch. Instead of betting everything on a single blastoff moment, adaptive launches evolve in real time—rerouting, adjusting, and responding to the market as it changes.

Participants identified four recurring blockers:

  • Disconnected teams and tools
  • Siloed or inaccessible insights
  • Linear plans that collapse under change
  • Speed without strategic clarity

And perhaps most importantly: a culture that still clings to perfection over progress.

AI’s role isn’t just acceleration—it’s transformation

The workshop featured a compelling case study from Within3, highlighting how one pharma company turned a high-pressure, unfamiliar launch into a success by:

  • Building a cross-functional insight platform
  • Using AI to ask better questions, not just deliver faster answers
  • Replacing siloed workflows with real-time collaboration between medical and commercial teams

The result? Faster decision-making, smarter market adaptation, and a launch strategy that evolved with the landscape—not in spite of it.

From uncertainty to intelligent launch

This session was a call for transformation. The group outlined what it will take to build true launch intelligence:

  • Integrate insights from day one
  • Focus on outcomes, not outputs
  • Embrace iteration and continuous learning
  • Challenge outdated norms and internal silos

Ready to lead, not lag, in the launch revolution? Download the full workshop summary now.

Related Posts:

digital health tools

Digital health tools changed patient expectations – and life science is responding

The pandemic gave telehealth and other digital health tools a massive boost. Here’s how patient behaviors will continue to affect how pharma and medical device companies use technology to gain patient and HCP insights.

Summit Series: Webinar no.1: Beginning the Climb

Key learnings from Part One of the Summit Series – featuring launch leaders from AstraZeneca, Grifols, and Pfizer.
speaker bureau management

Guide to speaker bureau management: tips and best practices for the pharma industry

Compliance concerns are top of mind in effective speaker bureau management. What else do pharma leaders need to know?